3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
107
Precursor Cell Lymphoblastic Leukemia-Lymphoma
40
Recurrence
20
Leukemia
18
Burkitt Lymphoma
18
Lymphoma
17
Neoplasms, Plasma Cell
13
Lymphoma, Non-Hodgkin
13
Nausea
12
Lymphoma, Mantle-Cell
12
Vomiting
11
Waldenstrom Macroglobulinemia
10
Breast Neoplasms
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
9
Neoplasms
9
Lymphoma, Follicular
9
Immunoglobulin Light-chain Amyloidosis
8
Lymphoma, B-Cell, Marginal Zone
7
Hodgkin Disease
7
Amyloidosis
7
Smoldering Multiple Myeloma
6
Lymphoma, Large B-Cell, Diffuse
6
Leukemia, Myeloid, Acute
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Prostatic Neoplasms
5
Leukemia, Biphenotypic, Acute
5
Hematologic Neoplasms
5
Sezary Syndrome
4
Mycosis Fungoides
4
Lymphoma, T-Cell, Cutaneous
4
Interventions
Gemcitabine
47
Cisplatin
32
pembrolizumab
28
Paclitaxel
13
Docetaxel
13
avelumab
12
Mitomycin
12
atezolizumab
11
Nivolumab
11
Cystectomy
10
Carboplatin
9
durvalumab
7
Sunitinib
7
apaziquone
6
Doxorubicin
6
BCG Vaccine
6
5-aminolevulinic acid hexyl ester
6
Vinblastine
5
Radiation
5
Platinum
5
Methotrexate
5
Magnetic Resonance Spectroscopy
5
Albumin-Bound Paclitaxel
5
Taxes
4
Standard of Care
4
Sorafenib
4
Radiotherapy
4
Fluorouracil
4
Erlotinib Hydrochloride
4
1,2-diaminocyclohexaneplatinum II citrate
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Urinary Bladder Neoplasms
×
Calcium Dobesilate
×
Clear all
No trials found.